Millennium Management
TXG icon

Millennium Management’s 10x Genomics TXG Stock Holding History

Millennium Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,000
Closed -$486K – 6492
2024
Q2 		$486K Sell
25,000
-5,000
-17% -$131K ﹤0.01% 4612
2024
Q1 		$1.13M Buy
30,000
+20,000
+200% +$879K ﹤0.01% 4195
2023
Q4 		$560K Buy
+10,000
New +$435K ﹤0.01% 4574
2022
Q3 		– Sell
-10,100
Closed -$457K – 7510
2022
Q2 		$457K Buy
+10,100
New +$524K ﹤0.01% 5031

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management's TXG Position: Q1 2026 in Review

Millennium Management increased its 10x Genomics (TXG) stake by 66% in Q1 2026, buying an estimated $16.5M and bringing the position to 2,068,414 shares worth $43.9M. The position accounts for 0.02% of the portfolio, ranked #918.

Millennium Management first reported a position in TXG in Q3 2019 and has held it in 24 quarters since. The position peaked at $63.6M in Q3 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Millennium Management held 2,068,414 shares of 10x Genomics worth $43.9M as of Q1 2026.
  • Millennium Management bought 826,048 10x Genomics shares in Q1 2026, an estimated $16.5M.
  • 10x Genomics made up 0.02% of Millennium Management's portfolio in Q1 2026, its #918 holding.
  • Millennium Management first reported a position in 10x Genomics in Q3 2019 and has held it in 24 quarters since.
  • Millennium Management's 10x Genomics position peaked at $63.6M in Q3 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.